131I-MIBG Therapy in metastatic phaeochromocytoma and paraganglioma

被引：0
|
作者：
Gonca Kara Gedik
Cornelis A. Hoefnagel
Evert Bais
Renato A. Valdés Olmos
机构：
[1] Hacettepe University School of Medicine,Department of Nuclear Medicine, Faculty of Medicine
[2] The Netherlands Cancer Institute,Department of Nuclear Medicine
[3] The Netherlands Cancer Institute,Department of Medical Oncology
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2008年 / 35卷
关键词：
I-MIBG; Phaeochromocytoma; Paraganglioma; Malignant; Radionuclide therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：725 / 733
页数：8
相关论文
共 50 条
  • [1] 131I-MIBG Therapy in metastatic phaeochromocytoma and paraganglioma
    Gedik, Gonca Kara
    Hoefnagel, Cornelis A.
    Bais, Evert
    Olmos, Renato A. Valdes
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (04) : 725 - 733
  • [2] Dosimetry for 131I-MIBG therapies in metastatic neuroblastoma, phaeochromocytoma and paraganglioma
    Sudbrock, Ferdinand
    Schmidt, Matthias
    Simon, Thorsten
    Eschner, Wolfgang
    Berthold, Frank
    Schicha, Harald
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (07) : 1279 - 1290
  • [3] Dosimetry for 131I-MIBG therapies in metastatic neuroblastoma, phaeochromocytoma and paraganglioma
    Ferdinand Sudbrock
    Matthias Schmidt
    Thorsten Simon
    Wolfgang Eschner
    Frank Berthold
    Harald Schicha
    European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 1279 - 1290
  • [4] Long-term efficacy of 131I-MIBG therapy in malignant paraganglioma and phaeochromocytoma
    Castellani, M. R.
    Luksch, R.
    Seregni, E.
    Maccauro, M.
    Chiesa, C.
    Aliberti, G.
    Orunesu, E.
    Bombardieri, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S218 - S218
  • [5] Adjuvant use of 131I-MIBG in phaeochromocytoma and paraganglioma at high risk of malignancy
    Rutherford, M. A.
    Rankin, A. J.
    Yates, T. M.
    Reed, N. S.
    Perry, C. G.
    Freel, E. M.
    SCOTTISH MEDICAL JOURNAL, 2013, 58 (01) : E61 - E61
  • [6] 131I-MIBG treatment in patients with metastatic paraganglioma and pheocrhomocytoma
    Bernal, J.
    Prado, S.
    Agudelo, M.
    Utrera, A.
    Canon, J.
    Bello, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S690 - S690
  • [7] Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with 131I-meta-iodobenzylguanidine (131I-mIBG)
    Mukherjee, JJ
    Kaltsas, GA
    Islam, N
    Plowman, PN
    Foley, R
    Hikmat, J
    Britton, KE
    Jenkins, PJ
    Chew, SL
    Monson, JP
    Besser, GM
    Grossman, AB
    CLINICAL ENDOCRINOLOGY, 2001, 55 (01) : 47 - 60
  • [8] Repeated Radionuclide therapy in metastatic paraganglioma leading to the highest reported cumulative activity of 131I-MIBG
    Samer Ezziddin
    Amir Sabet
    Yon-Dschun Ko
    Sunny Xun
    Alexander Matthies
    Hans-Jürgen Biersack
    Radiation Oncology, 7
  • [9] Repeated Radionuclide therapy in metastatic paraganglioma leading to the highest reported cumulative activity of 131I-MIBG
    Ezziddin, Samer
    Sabet, Amir
    Ko, Yon-Dschun
    Xun, Sunny
    Matthies, Alexander
    Biersack, Hans-Juergen
    RADIATION ONCOLOGY, 2012, 7
  • [10] Evaluation of the efficacy of 131I-MIBG therapy for metastatic neuroendocrine tumours
    Lapinska, G. E.
    Niewiadomska, J.
    Benke, M.
    Czetwertynska, M.
    Falkowski, S.
    Kozlowicz-Gudzinska, I.
    Sackiewicz-Slaby, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S222 - S222
12345